Concepedia

Myriam Delaunay

MD

Statistics

Publications

8

Citations

974

H-Index

8

Active since

2017

Affiliations

Inserm(Current)

Hôpital Larrey

Centre Hospitalier Universitaire de Toulouse

Institut Claudius Regaud

Centre de Recherches en Cancérologie de Toulouse

Myriam Delaunay is an author at Inserm specializing in oncology, cancer immunotherapy, and medicine.

Publications per year

2017–2023

8

Publications

8

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

Myriam Delaunay, J. Cadranel, Amélie Lusque et al. · European Respiratory Journal · 2017 · 421 citations · Full text

Medicine, Immunology, Oncology +15

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab

Nicolas Guibert, Myriam Delaunay, Amélie Lusque et al. · Lung Cancer · 2018 · 232 citations

Medicine, Immunology, Oncology +14

Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer

Nicolas Guibert, Greg Jones, John F. Beeler et al. · Lung Cancer · 2019 · 105 citations · Full text

Medicine, Molecular Biology, Oncology +15

Monitoring of <i>KRAS</i>-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma

Nicolas Guibert, Julien Mazières, Myriam Delaunay et al. · Oncotarget · 2017 · 90 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients

Élisa Gobbini, Anne Claire Toffart, M. Pérol et al. · Clinical Lung Cancer · 2020 · 76 citations · Full text

Life Sciences, Immunology, Oncology +12

1–5 of 8